Six Years Follow-Up of an 11-Year-Old Girl with Anti-HMGCR Myopathy

  • Dilek Cavusoglu
  • , Beril Talim
  • , Gazanfer Ekinci
  • , Haluk Topaloglu

Research output: Contribution to journalArticlepeer-review

Abstract

Anti-HMGCR myopathy is decribed as an immune-mediated necrotizing myopathy which is characterised by subacute, progressive proximal muscle weakness and elevated creatine kinase (CK) level. In pediatric population, anti-HMGCR myopathy has been reported solely as small case reports, albeit rare. Although treatment consensus has not yet been established, proper treatment with several immunomodulators to include IVIg can show remarkable improvement. We report an 11-year-old-girl diagnosed with anti-HMGCR myopathy with 6 years of follow-up.

Original languageEnglish
Pages (from-to)883-887
Number of pages5
JournalJournal of Neuromuscular Diseases
Volume11
Issue number4
DOIs
Publication statusPublished - 2 Jul 2024

Keywords

  • Anti-HMGCR myopathy
  • children
  • muscle weakness
  • treatment

Fingerprint

Dive into the research topics of 'Six Years Follow-Up of an 11-Year-Old Girl with Anti-HMGCR Myopathy'. Together they form a unique fingerprint.

Cite this